These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7614959)

  • 21. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17).
    Werner G; Fleige C; Ewert B; Laverde-Gomez JA; Klare I; Witte W
    Int J Antimicrob Agents; 2010 Feb; 35(2):119-25. PubMed ID: 20006472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa.
    Chen HY; Yuan M; Ibrahim-Elmagboul IB; Livermore DM
    J Antimicrob Chemother; 1995 Apr; 35(4):521-34. PubMed ID: 7628986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance in clinical isolates of Enterococcusfaecalis encountered at the University Hospital of the West Indies, Jamaica.
    Saunders GL; Bodonaik NC
    West Indian Med J; 2006 Jun; 55(3):194-6. PubMed ID: 17087105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.
    Piekarska K; Gierczyński R; Ławrynowicz-Paciorek M; Kochman M; Jagielski M
    Pol J Microbiol; 2008; 57(2):121-4. PubMed ID: 18646399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G; Derbentli S
    Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of clinical bacterial isolates to ciprofloxacin in the United States.
    Thornsberry C
    Infection; 1994; 22 Suppl 2():S80-9. PubMed ID: 7927835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of difloxacin against canine bacterial isolates.
    van den Hoven R; Wagenaar JA; Walker RD
    J Vet Diagn Invest; 2000 May; 12(3):218-23. PubMed ID: 10826834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method.
    Mendes RE; Farrell DJ; Sader HS; Flamm RK; Jones RN
    Antimicrob Agents Chemother; 2015 Jan; 59(1):702-6. PubMed ID: 25348529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli.
    Ogbolu DO; Terry-Alli OA; Daini OA; Olabiyi FA; Igharo EA
    Afr J Med Med Sci; 2012 Jun; 41(2):135-40. PubMed ID: 23185910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A; Joseph J; Sharma S; Nutheti R; Garg P; Das T
    Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence and antimicrobial resistance in clinical Enterococcus faecium.
    Billström H; Lund B; Sullivan A; Nord CE
    Int J Antimicrob Agents; 2008 Nov; 32(5):374-7. PubMed ID: 18715765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
    Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
    Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.